Medisolv Funding: How Much Did They Raise & Key Investors

How Much Did Medisolv Raise?
Funding & Key Investors

Medisolv has solidified its market position through a significant capital infusion, bringing its total funding to $1M. This latest injection of $1M represents a major strategic investment aimed at accelerating the deployment of its enterprise-grade quality management infrastructure. By securing this financing, the firm reinforces its commitment to streamlining complex regulatory reporting requirements for healthcare providers across the United States.

The capital allocation underscores the growing demand for sophisticated data management tools in an increasingly regulated clinical environment. As healthcare organizations navigate the complexities of CMS and TJC reporting, Medisolv continues to serve as a critical partner in ensuring compliance and operational efficiency through its proprietary ENCOR platform.

What is Medisolv?

Medisolv

Software

Healthcare Software

Medisolv operates as a premier provider of healthcare quality data management solutions. Its flagship product, ENCOR, functions as an all-in-one ecosystem designed to facilitate core measure abstraction, electronic measure capture, and comprehensive data aggregation. The platform is uniquely positioned to support both hospital and ambulatory settings, providing seamless integration with diverse reporting entities including ACOs and state-level organizations.

As a 2022 CMS-approved MIPS Qualified Clinical Data Registry, Medisolv maintains a competitive edge by ensuring its technology remains 2015 Cures Edition ONC certified. This technical rigor allows healthcare systems to automate the submission of electronic clinical quality measures (eCQMs), effectively reducing the administrative burden associated with value-based care initiatives and quality performance tracking.

How much funding has Medisolv raised?

Medisolv has raised a total of $1M across 1 funding round:

2020

Debt

$1M

Debt (2020): $1M with participation from PPP

Key Investors in Medisolv

PPP

Public-Private Partnership

What's next for Medisolv?

With this recent strategic investment, Medisolv is well-positioned to scale its enterprise operations and enhance the analytical capabilities of the ENCOR suite. The company is expected to focus on expanding its footprint within the ambulatory market while deepening its integration capabilities with emerging electronic health record systems. By leveraging this capital, Medisolv aims to further solidify its role as an essential infrastructure provider for health systems striving to meet the rigorous demands of modern quality reporting.

Future growth trajectories will likely involve the refinement of its QCDR services and the development of advanced predictive analytics to help providers proactively manage their quality scores. As the regulatory landscape continues to evolve, Medisolv remains at the forefront of digital health transformation, providing the necessary tools for organizations to thrive in a value-based reimbursement model.

See full Medisolv company page

See More Financial Insights